BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• 

  How to Stay Productive at Work During the Holidays

  Here’s how to block out the holiday madness at work so you can focus for at least a few hours a day.

  December 10, 2019

   · 

  2 min read

   · 

  Laura Brothers
• 

  Dressing the Part: What Does Business Casual Attire Look Like for Men and Women?

  In order to dress appropriately, it’s important to first understand exactly what business casual attire means, consists of and how it differs from your other options.

  December 10, 2019

   · 

  3 min read

   · 

  Kymberlie Krieger
• 

  Business

  Flagship Pioneering Launches New Company to Discover Medicines Targeting Cellular Behavior

  The new company, based in Cambridge, Mass., launched with a platform that “digitizes and quantifies cellular behaviors” in order to understand the dynamics that govern those behaviors.

  December 10, 2019

   · 

  3 min read

   · 

  Alex Keown
• 

  Drug Development

  ASH Roundup: Bristol-Myers Squibb, bluebird bio, Oryzon and More

  As the 61st American Society of Hematology Annual Meeting wrapped up in Orlando, Florida, there were hundreds of studies and results presented. Here’s a look at some.

  December 10, 2019

   · 

  3 min read

   · 

  Mark Terry
• 

  Drug Development

  Top 10 Clinical Trial Indications in the Bay State

  BioSpace put together a list of the top 10 indications being researched in the area by pharma companies, academic institutions and other organizations.

  December 10, 2019

   · 

  3 min read

   · 

  Alex Keown
• 

  Drug Development

  Following Strong Phase III Results, BMS Plans to Seek Approval for AML Candidate CC-486

  Bristol-Myers Squibb is looking to start 2020 on the right foot by filing a New Drug Application for its acute myeloid leukemia treatment CC-486 after data shows the medication extends survival time for AML patients.

  December 10, 2019

   · 

  2 min read

   · 

  Alex Keown
• 

  Business

  Truvian Sciences Moves Closer to Commercialization of Benchtop Blood Testing System

  “We still have some work in front of us, but we’re happy where we are,” said Jeff Hawkins, CEO of Truvian Sciences.

  December 10, 2019

   · 

  3 min read

   · 

  Alex Keown
• 

  Business

  Sanofi CEO Unveils New Strategy That Does Not Include Diabetes Research

  Despite having one of the best-selling insulin products on the market, Sanofi is exiting diabetes and cardiovascular research and development in favor of more lucrative areas, particularly cancer research.

  December 10, 2019

   · 

  3 min read

   · 

  Alex Keown
• 

  FDA

  FDA Gives Thumbs-up to EtectRx’s Wireless Smart Pills

  The company calls the system the first and only “ingestible event marker to transmit digital messages” from inside the body to a receiver without need for direct skin contact.

  December 10, 2019

   · 

  2 min read

   · 

  Mark Terry
• 

  Biotech Bay

  GigaGen’s Recombinant IVIG Technology Could Be Potential Solution to Global Shortage

  A critical supply shortage of intravenous immunoglobulin (IVIG) in the United States has left some room for doubt about whether or not that critical care will make it to some patients.

  December 10, 2019

   · 

  3 min read

   · 

  Alex Keown